TABLE 5.
Subnetwork enrichment analysis on gene dataset of p < 0.05, FDR.
Expression target | 1321N1 No. of overlapping entities | 1321N1 p-value | LN18 No. of overlapping entities | LN18 p-value |
---|---|---|---|---|
MYC | 113 | 2.93E-17 | n/a | n/a |
AKT1 | 137 | 2.35E-16 | 136 | 5.16E-10 |
TGFB1 | 228 | 3.31E-13 | n/a | n/a |
HIF1A | 117 | 1.98E-12 | 117 | 1.28E-07 |
EGR1 | 77 | 4.94E-12 | n/a | n/a |
JUN | 105 | 5.20E-12 | n/a | n/a |
NFE2L2 | 72 | 7.90E-12 | 75 | 2.05E-09 |
KLF4 | 53 | 9.72E-11 | n/a | n/a |
MAP2K1 | 54 | 1.95E-10 | n/a | n/a |
FGF2 | 107 | 3.23E-09 | n/a | n/a |
ATF4 | 37 | 3.36E-09 | 37 | 3.96E-07 |
PARP1 | 41 | 4.13E-09 | n/a | n/a |
FOXM1 | 46 | 2.05E-08 | n/a | n/a |
EIF2AK3 | 27 | 2.60E-08 | 25 | 1.19E-05 |
NFYA | 26 | 3.20E-08 | n/a | n/a |
EDN1 | 60 | 4.08E-08 | n/a | n/a |
ATF3 | 32 | 4.44E-08 | n/a | n/a |
VEGFA | 76 | 6.04E-08 | n/a | n/a |
E2F4 | n/a | n/a | 27 | 1.04E-08 |
MTOR | n/a | n/a | 88 | 1.24E-08 |
E2F1 | n/a | n/a | 74 | 5.72E-08 |
BRCA1 | n/a | n/a | 34 | 8.09E-08 |
SRSF3 | n/a | n/a | 13 | 6.18E-07 |
HSP90AA1 | n/a | n/a | 38 | 3.00E-06 |
CUL4A | n/a | n/a | 11 | 8.03E-06 |
VCP | n/a | n/a | 13 | 1.66E-05 |
CAPN2 | n/a | n/a | 16 | 2.17E-05 |
CDC20 | n/a | n/a | 12 | 2.93E-05 |
CUL1 | n/a | n/a | 12 | 2.93E-05 |
EGFR | n/a | n/a | 70 | 3.17E-05 |
DDIT3 | n/a | n/a | 28 | 3.68E-05 |
NRG1 | n/a | n/a | 40 | 4.68E-05 |
SOD1 | n/a | n/a | 20 | 6.78E-05 |
SREBF1 | n/a | n/a | 41 | 6.83E-05 |